2016
DOI: 10.1039/c6an00417b
|View full text |Cite
|
Sign up to set email alerts
|

High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT

Abstract: Reversible cysteine modifications play important physiological roles such as modulating enzymatic catalysis, maintaining redox homeostasis and conducting cellular signaling. These roles can be critical in the context of disease. Oxidative modifications such as S-nitrosylation (SNO) are signatures of neurodestruction in conditions of oxidative stress however are also indicators of neuroprotection and normal signaling in cellular environments with low concentrations of reactive oxygen and nitrogen species. SNO i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
48
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 31 publications
(49 citation statements)
references
References 52 publications
1
48
0
Order By: Relevance
“…By combining isotopic and isobaric labeling, highly multiplexed quantification can be achieved with RAC for redox proteomics. 108110 The covalent capture and immobilization of free thiol-containing protein/peptides using the RAC approach allows for more stringent washing to further reduce contaminants and non-specific binding. Isobaric labeling coupled with RAC allows for multiplexed quantification and stoichiometric measurement for multiple Cys redox PTMs, including SNO, SSG and total thiol oxidation 66, 69, 73, 79, 80 .…”
Section: Proteomic Strategies For Characterizing Reversible Cys Ptmsmentioning
confidence: 99%
“…By combining isotopic and isobaric labeling, highly multiplexed quantification can be achieved with RAC for redox proteomics. 108110 The covalent capture and immobilization of free thiol-containing protein/peptides using the RAC approach allows for more stringent washing to further reduce contaminants and non-specific binding. Isobaric labeling coupled with RAC allows for multiplexed quantification and stoichiometric measurement for multiple Cys redox PTMs, including SNO, SSG and total thiol oxidation 66, 69, 73, 79, 80 .…”
Section: Proteomic Strategies For Characterizing Reversible Cys Ptmsmentioning
confidence: 99%
“…Alzheimer's disease is a neurodegenerative disorder characterized by neurofibrillary tangles, senile plaques, loss of synapses among other pathological hallmarks and has well‐known oxidative stress in brain , plasma , heart , spleen , and liver tissues. Similar to aging, cysteine reversible modifications are also implicated in AD pathogenesis.…”
Section: Applications Of Cysteine‐selective Redox Proteomics In Agingmentioning
confidence: 99%
“…To date, numerous approaches have been developed and applied in biological studies, e.g. oxidized isotopecoded affinity tag [37], oxidized isobaric tag for relative and absolute quantitation [45], SNO analysis by resin-assisted capture [36], oxidized multiple reaction monitoring [40], cysteine tandem mass tags and isobaric tag for relative and absolute quantification [48], and two approaches developed by our laboratory: oxidized cysteine-selective dimethylation (OxcysDML) [76] and oxidized cysteine-selective cPILOT (OxcyscPILOT) [77]. Compared with global protein quantification, more variables have to be considered for cysteine redox quantification, such as the modification type investigated, the number of sample multiplexing channels required, the incorporation of chemical mass tags, the enrichment method, amount of starting material, and method for stoichiometric quantitation.…”
Section: Redox Proteomic Approaches To Quantify Cysteine Reversible Mmentioning
confidence: 99%
“…Comprehensive and site-specific analysis of protein modifications is normally beyond the reach of conventional biochemistry methods. Modern MS technology provides a unique opportunity to globally and site-specifically characterize protein modifications (Ficarro et al, 2002;Peng et al, 2003;Trinidad et al, 2006;Siuti and Kelleher, 2007;Witze et al, 2007;Yates et al, 2009;Mertins et al, 2013;Nwosu et al, 2013;Huang et al, 2015a;Ludwig et al, 2015;Gu and Robinson, 2016;Lossl et al, 2016;Yue et al, 2016;Cao et al, 2017;Simithy et al, 2017;Hogrebe et al, 2018;Wu et al, 2018). However, it is still extraordinarily challenging to globally analyze them because of the low abundance of many modified proteins, sub-stoichiometry of protein modifications, and the complexity of biological samples.…”
Section: Introductionmentioning
confidence: 99%